Deep learning-enabled breast cancer hormonal receptor status determination from base-level H&E stains
Nature communications, pp. 5727-5727, 2020.
For newly diagnosed breast cancer, estrogen receptor status (ERS) is a key molecular marker used for prognosis and treatment decisions. During clinical management, ERS is determined by pathologists from immunohistochemistry (IHC) staining of biopsied tissue for the targeted receptor, which highlights the presence of cellular surface antig...More
Full Text (Upload PDF)
PPT (Upload PPT)